Evidence map›Paper›PMID 22185757›Full record

ArticleCell cycle (Georgetown, Tex.)2012

Autophagic removal of micronuclei.

Santiago Rello-Varona, Delphine Lissa, Shensi Shen, Mireia Niso-Santano, Laura Senovilla, Guillermo Mariño, Ilio Vitale, Mohamed Jemaá, Francis Harper, Gérard Pierron and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Micronuclei: origins, assays, mechanisms, diseases and treatments.Signal transduction and targeted therapy · 2026
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Chromothripsis in cancer.Nature reviews. Cancer · 2025
    Review
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Santiago Rello-VaronaINSERM, U848, Orsay, Paris, France.
Delphine Lissa
Shensi Shen
Mireia Niso-Santano
Laura Senovilla
Guillermo Mariño
Ilio Vitale
Mohamed Jemaá
Francis Harper
Gérard Pierron
Maria Castedo
Guido Kroemer

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macroautophagy is known to participate in the quality control and turnover of cytoplasmic organelles, yet there is little evidence that macroautophagy targets nuclei in mammalian cells. Here, we investigated whether autophagy may target micronuclei, which arise as a result of deficient bipolar chromosome segregation in cells exposed to cell cycle perturbations. After removal of several distinct cell cycle blockers (nocodazole, cytochalasin D, hydroxyurea or SP600125), cells manifested an increase in the frequency of micronuclei (positive for histone H2B-RFP) as well as an increase in autophagic puncta (positive for GFP-LC3) over several days. A small but significant percentage of micronuclei co-localized with GFP-LC3 in autophagy-competent cells and this co-localization was lost after knockdown of ATG5 or ATG7. Electron microscopy analyses confirmed autophagic sequestration of micronuclei. "Autophagic micronuclei" (GFP-LC3⁺) were also decorated with p62/SQSTM1, while non-autophagic (GFP-LC3⁻) micronuclei where p62/SQSTM1 negative. In addition, GFP-LC3⁺ micronuclei exhibited signs of envelope degradation and γH2AX⁺ DNA damage foci, yet stained less intensively for chromatin markers, whereas GFP-LC3⁻ micronuclei were surrounded by an intact envelope and rarely exhibited markers or DNA damage. These results indicate that micronuclei can be subjected to autophagic degradation. Moreover, it can be speculated that removal of micronuclei may contribute to the genome-stabilizing effects of autophagy.

Indexed as

AutophagyAutophagy-Related Protein 5Autophagy-Related Protein 7Cell Line, TumorCell NucleusDNA DamageHistonesHumansMicronuclei, Chromosome-DefectiveMicrotubule-Associated ProteinsNuclear EnvelopeRecombinant Fusion ProteinsRNA InterferenceRNA, Small InterferingUbiquitin-Activating EnzymesATG5 protein, humanATG7 protein, humanAutophagy-Related Protein 5Autophagy-Related Protein 7H2AX protein, humanHistonesMAP1LC3A protein, humanMicrotubule-Associated ProteinsRecombinant Fusion ProteinsRNA, Small InterferingUbiquitin-Activating Enzymes

Identifiers

PMID22185757

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.